{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:46:35Z","timestamp":1781214395120,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"DOI":"10.1038\/emm.2016.27","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T07:01:50Z","timestamp":1463122910000},"page":"e232-e232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease"],"prefix":"10.1038","volume":"48","author":[{"given":"Mi-Young","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Ok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binna","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Suk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Sook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"key":"BFemm201627_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5604\/17322693.1003484","volume":"66","author":"J Lis","year":"2012","unstructured":"Lis J, Jarzab A, Witkowska D . [Molecular mimicry in the etiology of autoimmune diseases]. Postepy Hig Med Dosw (Online) 2012; 66: 475\u2013491.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"BFemm201627_CR2","first-page":"1","volume":"102","author":"A Perl","year":"2004","unstructured":"Perl A . Pathogenesis and spectrum of autoimmunity. Methods Mol Med 2004; 102: 1\u20138.","journal-title":"Methods Mol Med"},{"key":"BFemm201627_CR3","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1098\/rstb.2011.0030","volume":"366","author":"CJ Taylor","year":"2011","unstructured":"Taylor CJ, Bolton EM, Bradley JA . Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci 2011; 366: 2312\u20132322.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFemm201627_CR4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1590\/S0100-879X2006005000166","volume":"40","author":"SB Rosa","year":"2007","unstructured":"Rosa SB, Voltarelli JC, Chies JA, Pranke P . The use of stem cells for the treatment of autoimmune diseases. Braz J Med Biol Res 2007; 40: 1579\u20131597.","journal-title":"Braz J Med Biol Res"},{"key":"BFemm201627_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.coi.2010.10.012","volume":"22","author":"A Uccelli","year":"2010","unstructured":"Uccelli A, Prockop DJ . Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 2010; 22: 768\u2013774.","journal-title":"Curr Opin Immunol"},{"key":"BFemm201627_CR6","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/mt.2008.102","volume":"16","author":"MH Parker","year":"2008","unstructured":"Parker MH, Kuhr C, Tapscott SJ, Storb R . Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs. Mol Ther 2008; 16: 1340\u20131346.","journal-title":"Mol Ther"},{"key":"BFemm201627_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA . Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010; 5: 933\u2013946.","journal-title":"Regen Med"},{"key":"BFemm201627_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/emmm.201000060","volume":"2","author":"F Gage","year":"2010","unstructured":"Gage F . The promise and the challenge of modelling human disease in a dish. EMBO Mol Med 2010; 2: 77\u201378.","journal-title":"EMBO Mol Med"},{"key":"BFemm201627_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","volume":"5","author":"MH Chin","year":"2009","unstructured":"Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111\u2013123.","journal-title":"Cell Stem Cell"},{"key":"BFemm201627_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861\u2013872.","journal-title":"Cell"},{"key":"BFemm201627_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrm2466","volume":"9","author":"S Nishikawa","year":"2008","unstructured":"Nishikawa S, Goldstein RA, Nierras CR . The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008; 9: 725\u2013729.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFemm201627_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-62703-348-0_3","volume":"997","author":"N Malik","year":"2013","unstructured":"Malik N, Rao MS . A review of the methods for human iPSC derivation. Methods Mol Biol 2013; 997: 23\u201333.","journal-title":"Methods Mol Biol"},{"key":"BFemm201627_CR13","doi-asserted-by":"publisher","first-page":"e115198","DOI":"10.1371\/journal.pone.0115198","volume":"9","author":"T Ikeda","year":"2014","unstructured":"Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE 2014; 9: e115198.","journal-title":"PLoS ONE"},{"key":"BFemm201627_CR14","first-page":"9","volume":"2","author":"M Li","year":"2014","unstructured":"Li M, Ikehara S . Stem cell treatment for type 1 diabetes. Front Cell Dev Biol 2014; 2: 9.","journal-title":"Front Cell Dev Biol"},{"key":"BFemm201627_CR15","doi-asserted-by":"publisher","first-page":"15768","DOI":"10.1073\/pnas.0906894106","volume":"106","author":"R Maehr","year":"2009","unstructured":"Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 2009; 106: 15768\u201315773.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm201627_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/path.4551","volume":"237","author":"MY Son","year":"2015","unstructured":"Son MY, Kwak JE, Seol B, Lee da Y, Jeon H, Cho YS . A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation. J Pathol 2015; 237: 98\u2013110.","journal-title":"J Pathol"},{"key":"BFemm201627_CR17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/hmg\/ddt571","volume":"23","author":"MY Son","year":"2014","unstructured":"Son MY, Seol B, Han YM, Cho YS . Comparative receptor tyrosine kinase profiling identifies a novel role for AXL in human stem cell pluripotency. Hum Mol Genet 2014; 23: 1802\u20131816.","journal-title":"Hum Mol Genet"},{"key":"BFemm201627_CR18","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/stem.1509","volume":"31","author":"MY Son","year":"2013","unstructured":"Son MY, Choi H, Han YM, Cho YS . Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency. Stem Cells 2013; 31: 2374\u20132387.","journal-title":"Stem Cells"},{"key":"BFemm201627_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011; 8: 409\u2013412.","journal-title":"Nat Methods"},{"key":"BFemm201627_CR20","doi-asserted-by":"publisher","first-page":"e17829","DOI":"10.1371\/journal.pone.0017829","volume":"6","author":"G Salvagiotto","year":"2011","unstructured":"Salvagiotto G, Burton S, Daigh CA, Rajesh D, Slukvin II, Seay NJ . A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. PLoS ONE 2011; 6: e17829.","journal-title":"PLoS ONE"},{"key":"BFemm201627_CR21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/stem.1368","volume":"31","author":"MJ Son","year":"2013","unstructured":"Son MJ, Son MY, Seol B, Kim MJ, Yoo CH, Han MK et al. Nicotinamide overcomes pluripotency deficits and reprogramming barriers. Stem Cells 2013; 31: 1121\u20131135.","journal-title":"Stem Cells"},{"key":"BFemm201627_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00296-013-2704-5","volume":"33","author":"Y Chen","year":"2013","unstructured":"Chen Y, Luo R, Xu Y, Cai X, Li W, Tan K et al. Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine. Rheumatol Int 2013; 33: 2127\u20132134.","journal-title":"Rheumatol Int"},{"key":"BFemm201627_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618\u2013630.","journal-title":"Cell Stem Cell"},{"key":"BFemm201627_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2010.06.003","volume":"7","author":"T Seki","year":"2010","unstructured":"Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7: 11\u201314.","journal-title":"Cell Stem Cell"},{"key":"BFemm201627_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4: 381\u2013384.","journal-title":"Cell Stem Cell"},{"key":"BFemm201627_CR26","doi-asserted-by":"publisher","first-page":"e17557","DOI":"10.1371\/journal.pone.0017557","volume":"6","author":"J Yu","year":"2011","unstructured":"Yu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y . Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE 2011; 6: e17557.","journal-title":"PLoS ONE"},{"key":"BFemm201627_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.stem.2011.03.001","volume":"8","author":"F Anokye-Danso","year":"2011","unstructured":"Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376\u2013388.","journal-title":"Cell Stem Cell"},{"key":"BFemm201627_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797\u2013801.","journal-title":"Science"},{"key":"BFemm201627_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.bbmt.2012.06.003","volume":"18","author":"MC Pasquini","year":"2012","unstructured":"Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW et al. Transplantation for autoimmune diseases in North and South America: a report of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2012; 18: 1471\u20131478.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFemm201627_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4067\/S0716-97602012000300008","volume":"45","author":"FE Figueroa","year":"2012","unstructured":"Figueroa FE, Carrion F, Villanueva S, Khoury M . Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res 2012; 45: 269\u2013277.","journal-title":"Biol Res"}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/emm201627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm201627","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/emm201627.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:23:53Z","timestamp":1672820633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm201627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,13]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["BFemm201627"],"URL":"https:\/\/doi.org\/10.1038\/emm.2016.27","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,13]]},"assertion":[{"value":"23 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}